Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

‘Volcon On Track To Release First Electric Bicycle Soon’ -InsideEVs Report

https://insideevs.com/news/606967/volocn-brat-teased-socia-media/amp/
byBenzinga Newsdesk
August 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://insideevs.com/news/606967/volocn-brat-teased-socia-media/amp/

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Camizestrant Significantly Improved Progression-free Survival vs. Faslodex in SERENA-2 Phase II Trial in Advanced ER-positive Breast Cancer

By Charles Gross
October 26, 4:47 AM
Positive high-level results from the SERENA-2 Phase II trial showed that AstraZeneca's next-generation oral selective estrogen receptor degrader (ngSERD) camizestrant met the primary endpoint of demonstrating a statistically significant and clinically meaningful progression-free survival (PFS) benefit at both 75mg and 150mg dose levels versus Faslodex (fulvestrant) 500mg in post-menopausal patient

AZN